Source: Pluristem Life Systems, Inc.
Posted: June 14, 2007 8:00 am ET
Summary:
Pluristem Life Systems, Inc., a bio-therapeutics Company dedicated to the commercialization of products for a variety of malignant, degenerative and auto-immune indications, announced today that Pluristem's PLacenta eXpanded (PLX) cells have been demonstrated in vitro to have properties that the company believes gives these cells the potential to treat Parkinson's Disease (PD). PLX cells are Pluristem's placental-derived mesenchymal stem cells (MSCs) that have been expanded in the Company's proprietary PluriX(TM) 3-D bioreactor. The lab experiment demonstrated that Pluristem's PLX cells can be differentiated into dopaminergic neurons. These neurons were found to have properties favorable to cells, which are known to be helpful in treating PD.
